Nippon India Pharma Fund-Bonus
Mutual Fund Details – Invest Smart, Grow Wealth
Discover a variety of mutual funds tailored to your goals, from equity and debt to hybrid options. Track performance, compare funds, and get expert insights to make informed investment decisions. Grow your wealth with Motilal Oswal’s trusted mutual fund solutions.
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return 1.98% at 05 Feb 2026 11:09 AM
Fund Details
NAV 496.5599
Sub-Type Sectoral-Pharma
Rating 3
Min. SIP Amount ₹100.0
Fund Age(Year) 21.67
Fund Size(in Crores) 8264.7
Fund Performance
1 Month -3.06%
3 Month -4.02%
6 Month -4.04%
1 Year 1.98%
3 Year 22.07%
5 Year 14.27%
Know This Fund
As on 05 Feb 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (97.37%) Market Cap Mid Cap 41.61 Small Cap 29.77 Large Cap 25.99 Top Sectors Healthcare 97.37 Top Holding Anthem Biosciences 0.83 Orchid Pharma 0.42 Apollo Hospitals Enterprise 5.53 Cipla 6.39 Syngene International 1.09 Vijaya Diagnostic Centre 3.71 Indoco Remedies 0.52 Max Healthcare Institute 1.13 Mankind Pharma 2.01 Aurobindo Pharma 2.44 Fortis Healthcare 1.18 Dr. Lal Pathlabs 2.19 Dr. Reddy's Laboratories 6.02 Astrazeneca Pharma India 0.68 Glaxosmithkline Pharma 2.73 Emcure Pharmaceuticals 1.23 Lupin 7.36 Alkem Laboratories 2.16 Akums Drugs And Pharmaceuticals 0.83 Suraksha Diagnostic 1.27 Sanofi Consumer Healthcare India 1.17 Abbott India 2.61 Sanofi India 1.14 Ajanta Pharma 3.21 Medplus Health Services 3.54 Gland Pharma 1.67 Divi's Laboratories 6.58 Thyrocare Technologies 2.37 Sun Pharmaceutical Industries 13.02 JB Chemicals 2.2 Sai Life Sciences 2.81 Concord Biotech 0.18 Ipca Laboratories 2.05 Narayana Hrudayalaya 2.12 Pfizer 1.92 Biocon 1.06
Debt & Others (2.63%) Sector Allocation Repo 1.64 Margin Money 0.01 Net Current Assets 0.98 Debt Credit Ratings Debt Category Others 2.63
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M -2.71% Ret 1Y 1.89% Ret 3Y 21.9% Ret 5Y 12.99%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M -2.71% Ret 1Y 1.89% Ret 3Y 21.9% Ret 5Y 12.99%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M -2.71% Ret 1Y 1.89% Ret 3Y 21.9% Ret 5Y 12.99%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -3.8% Ret 1Y -1.64% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -3.8% Ret 1Y -1.64% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -3.8% Ret 1Y -1.64% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M -4.34% Ret 1Y -1.42% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M -5.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M -5.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M -5.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M -3.11% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 1.82%
Exit Load 0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Sailesh Raj Bhan
Education Mr. Bhan is an MBA (Finance) and CFA.
Experience Prior to joining Nippon India Mutual Fund, he has worked with Emkay Share & Stock Broker Pvt. Ltd, Shah & Sequeira Invst. Pvt. Ltd, ICFAI- Securities Research Center Analyst - Equity Research.
Lokesh Maru
Education Bachelor of Technology, CFA, FRM
Experience Prior to joining the Nippon AMC, he was associated with BlackRock Services India Private Ltd, CRISIL Ltd.
Divya Dutt Sharma
Education Bachelor of Commerce, MSC Banking & Finance.
Experience Prior to joining the Nippon AMC, he was associated with Bhramrishi Mission NGO, Equations LLC, V.K Pamecha and Associates.
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 3
Date of Incorporation 2004-06-05
Total AUM 2025-12-31
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Take Your Next Step
